Eliaz Therapeutics is Raising Capital to Develop its Therapeutic Apheresis Device to Treat Acute Kidney Injury
/PRNewswire/ -- Berkery Noyes Securities is pleased to announce it has been retained by Eliaz Therapeutics ("ETI"), developer of a groundbreaking,...
Source: prnewswire.com